77 related articles for article (PubMed ID: 1824850)
1. Construction, expression, and biologic activity of murine/human chimeric antibodies with specificity for the human alpha/beta T cell receptor.
Shearman CW; Kanzy EJ; Lawrie DK; Li YW; Thammana P; Moore GP; Kurrle R
J Immunol; 1991 Feb; 146(3):928-35. PubMed ID: 1824850
[TBL] [Abstract][Full Text] [Related]
2. Construction, expression and characterization of humanized antibodies directed against the human alpha/beta T cell receptor.
Shearman CW; Pollock D; White G; Hehir K; Moore GP; Kanzy EJ; Kurrle R
J Immunol; 1991 Dec; 147(12):4366-73. PubMed ID: 1836485
[TBL] [Abstract][Full Text] [Related]
3. [Construction, expression and characterization of a murine/human chimeric antibody with specificity for hepatitis B surface antigen].
Li Y; Shearman CW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Oct; 12(5):318-24. PubMed ID: 2151688
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a human T cell-specific chimeric antibody (CD7) with human constant and mouse variable regions.
Heinrich G; Gram H; Kocher HP; Schreier MH; Ryffel B; Akbar A; Amlot PL; Janossy G
J Immunol; 1989 Dec; 143(11):3589-97. PubMed ID: 2479683
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
[TBL] [Abstract][Full Text] [Related]
6. Cloning and expression of a chimeric antibody directed against the human transferrin receptor.
Hoogenboom HR; Raus JC; Volckaert G
J Immunol; 1990 Apr; 144(8):3211-7. PubMed ID: 2324499
[TBL] [Abstract][Full Text] [Related]
7. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
Coney LR; Mezzanzanica D; Sanborn D; Casalini P; Colnaghi MI; Zurawski VR
Cancer Res; 1994 May; 54(9):2448-55. PubMed ID: 7512887
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.
Portoles P; Rojo J; Golby A; Bonneville M; Gromkowski S; Greenbaum L; Janeway CA; Murphy DB; Bottomly K
J Immunol; 1989 Jun; 142(12):4169-75. PubMed ID: 2470817
[TBL] [Abstract][Full Text] [Related]
9. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1).
Hutzell P; Kashmiri S; Colcher D; Primus FJ; Hand PH; Roselli M; Finch M; Yarranton G; Bodmer M; Whittle N
Cancer Res; 1991 Jan; 51(1):181-9. PubMed ID: 1988082
[TBL] [Abstract][Full Text] [Related]
11. A human-mouse chimeric Lym-1 monoclonal antibody with specificity for human lymphomas expressed in a baculovirus system.
Hu P; Glasky MS; Yun A; Alauddin MM; Hornick JL; Khawli LA; Epstein AL
Hum Antibodies Hybridomas; 1995; 6(2):57-67. PubMed ID: 7492752
[TBL] [Abstract][Full Text] [Related]
12. Transfectomas expressing both secreted and membrane-bound forms of chimeric IgE with anti-viral specificity.
Sun LK; Liou RS; Sun NC; Gossett LA; Sun C; Davis FM; MacGlashan DW; Chang TW
J Immunol; 1991 Jan; 146(1):199-205. PubMed ID: 1701791
[TBL] [Abstract][Full Text] [Related]
13. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL
J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation.
Rose B; Gillespie A; Wunderlich D; Kelley K; Dzuiba J; Shedd D; Cahill K; Zerler B
Immunology; 1992 Jul; 76(3):452-9. PubMed ID: 1526654
[TBL] [Abstract][Full Text] [Related]
15. High-level expression and characterization of a mouse-human chimeric CD4 antibody with therapeutic potential.
Looney JE; Knight DM; Arevalo-Moore M; Trinh H; Pak KY; Dalesandro MR; Rieber EP; Riethmuller G; Daddona PE; Ghrayeb J
Hum Antibodies Hybridomas; 1992 Oct; 3(4):191-200. PubMed ID: 1477300
[TBL] [Abstract][Full Text] [Related]
16. Specific elimination of IgE production using T cell lines expressing chimeric T cell receptor genes.
Lustgarten J; Eshhar Z
Eur J Immunol; 1995 Oct; 25(10):2985-91. PubMed ID: 7589102
[TBL] [Abstract][Full Text] [Related]
17. Antigen-specific and antibody-mediated growth inhibition of suppressor T cell hybridomas. Roles of H-2 and the CD3-T cell receptor-alpha/beta complex.
Kuchroo VK; Billings PR; Levine C; Martin CA; Kubo RT; Dorf ME
J Immunol; 1990 Aug; 145(4):1059-65. PubMed ID: 2143205
[TBL] [Abstract][Full Text] [Related]
18. Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3).
Demanet C; Brissinck J; Van Mechelen M; Leo O; Thielemans K
J Immunol; 1991 Aug; 147(3):1091-7. PubMed ID: 1830596
[TBL] [Abstract][Full Text] [Related]
19. Recombinant mouse/human chimeric anti-colorectal carcinoma antibody cACT19.
Xiang J; Moyana T; Liu E
Hum Antibodies Hybridomas; 1994; 5(3-4):105-15. PubMed ID: 7756575
[TBL] [Abstract][Full Text] [Related]
20. Modulation of TCR-mediated signaling pathway by thymic shared antigen-1 (TSA-1)/stem cell antigen-2 (Sca-2).
Saitoh S; Kosugi A; Noda S; Yamamoto N; Ogata M; Minami Y; Miyake K; Hamaoka T
J Immunol; 1995 Dec; 155(12):5574-81. PubMed ID: 7499840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
